Trial intelligence / Profile preview

rhTPO for ITP in Pregnancy

NCT02391272Phase 3Completed

Sponsor
Shandong University
Start
Mar 2015
Primary completion
Nov 2015
Modality
Cytokines & Interferons
Countries
1
01

Overview

A Phase 3 trial of recombinant human thrombopoietin in immune thrombocytopenia (ITP), sponsored by Shandong University. Started Mar 2015; status: completed.

02

Drugs

recombinant human thrombopoietin
03

Conditions

immune thrombocytopenia (ITP)

Beyond the preview

Go deeper on NCT02391272.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02391272.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call